Novo Nordisk A/S ADR (NYSE:NVO) - Share price - Overview

Stock Report

Novo Nordisk A/S NVO

Last Price
$41.86

Day Change
0.19|0.46%

As of 25/05/2017
16:03:06 EDT | USD
Minimum 15 Minutes Delay.

Last Close41.67
Day Range41.45 - 41.92
Mkt Cap106.60Bil
52-Wk Range30.89 - 57.44
Yield %2.67
ISINUS6701002056
Volume1,136,164
P/E-
P/S6.22
P/CF13.28

Share Price

Financials
201420152016
More ...
Income Statement
Revenue88,806.00107,927.00111,780.00
Operating Income34,492.0049,444.0048,432.00
Net Income26,481.0034,860.0037,925.00
Basic EPS10.1013.5614.99
Avg. Diluted Shares Outstanding2,6302,5782,535
Balance Sheet
Current Assets46,293.0055,140.0059,766.00
Non Current Assets30,769.0036,659.0037,773.00
Total Assets77,062.0091,799.0097,539.00
Current Liabilities33,689.0040,873.0047,436.00
Total Liabilities36,768.0044,830.0052,270.00
Total Equity40,294.0046,969.0045,269.00
Cash Flow
Operating Cash Flow31,692.0038,287.0048,314.00
Capital Expenditure-4,335.00-6,406.00-8,267.00
Free Cash Flow27,357.0031,881.0040,047.00

In millions, except "Basic EPS". Currency is DKK.

Company Profile

Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

42,000
Key Stats
More ...
Price/Earning TTM-
Price/Book17.56
Price/Sales TTM-
Rev Growth (3 year avg)10.18
EPS Growth (3 year avg)-
Operating Margin % TTM43.33
Net Margin % TTM33.93
ROE TTM82.23
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Date05/08/1626/02/17
Ex-Div11/08/1623/03/17
Paid23/08/1604/04/17
Amnt0.450.66
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.